March 3, 2026

Haemorrhagic events in patients with transthyretin cardiac amyloidosis

Key Points

Bleeding complications are common in patients with transthyretin cardiac amyloidosis and are linked to higher HAS-BLED scores.
A HAS-BLED score of 2 or higher significantly increases the risk of haemorrhagic events in affected individuals.
Analysis indicates that anticoagulation use further elevates the risk of bleeding in this patient population.
These findings may inform risk stratification and therapeutic decisions for managing transthyretin cardiac amyloidosis.

Abstract

bleeding is a frequent complication in ATTR-CA, with a higher risk in those individuals with a HAS-BLED score ≥2 and/or on AC. These findings could be considered in risk stratification and therapeutic decision-making.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Lucía Moreno De Redrojo Cortés

Rocío Eiros Bachiller

Instituto de Estudios de Ciencias de la Salud de Castilla y León

Eduardo Villacorta Argüelles

Instituto de Estudios de Ciencias de la Salud de Castilla y León

Journals

Amyloid

Actions

Institutions

Centro de Investigación Biomédica en Red

Centro de Investigación en Red en Enfermedades Cardiovasculares

Instituto de Investigación Biomédica de Salamanca

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Haemorrhagic events in patients with transthyretin cardiac amyloidosis

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study